CJ
PBM icon

Caitlin John’s Psyence Biomedical PBM Stock Holding History

Caitlin John’s Portfolio PBM Stock Details PBM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$107 Buy
+35
New +$159 ﹤0.01% 986

Other funds holding PBM

PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
SFFS
Stonehage Fleming Financial Services St. Helier, Jersey $2.93B AUM 16.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Caitlin John's PBM Position: Q2 2026 in Review

Caitlin John opened a new position in Psyence Biomedical (PBM) in Q2 2026: 35 shares worth $107. The stake represents ﹤0.01% of the portfolio and ranks #986 among its holdings.

9 funds tracked by Wall St. Rank hold PBM as of Q2 2026.

  • Caitlin John held 35 shares of Psyence Biomedical worth $107 as of Q2 2026.
  • Psyence Biomedical was a new Caitlin John position in Q2 2026.
  • Psyence Biomedical made up ﹤0.01% of Caitlin John's portfolio in Q2 2026, its #986 holding.
  • 9 funds tracked by Wall St. Rank held Psyence Biomedical as of Q2 2026.

Based on Caitlin John's 13F filing for Q2 2026, filed 17 Aug 2026.